Akso Health Group AHG
Nasdaq · XNAS · stock · Services-Business Services, NEC · website · IPO 2017-11-03
Akso Health Group statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | -1.9% | 5.1% | 9.6% | 9.6% | 99.0% |
| Operating margin | -1125.4% | -357.8% | -108.2% | -51.7% | -239.3% |
| Net margin | -913.4% | -391.8% | -10.3% | -267.0% | -1964.8% |
| FCF margin | 6.9% | — | — | — | — |
| Return on assets | -62.8% | -6.7% | -6.6% | -26.8% | -109.9% |
| Return on equity | -67.8% | -6.8% | -15.4% | -137.2% | -201.6% |
| Current ratio | 14.20 | 39.52 | 1.76 | 1.24 | 2.09 |
| Revenue growth | 512.1% | -81.7% | 108.9% | 256.1% | -74.5% |
Source: SEC EDGAR filings · CIK 0001702318 · as of 2025-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.